Skip to main content
SpringerLink
Log in

Prognostic role of metabolic parameters (MTV and TLG) of staging PET/CT in the pediatric population with Hodgkin’s lymphoma: an open discussion

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Frood R, Burton C, Tsoumpas C, et al. Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review. Eur J Nucl Med Mol Imaging. 2021;48:3198–220. https://doi.org/10.1007/s00259-021-05233-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kluge R, et al. Current status of FDG-PET/CT in the treatment setting of Hodgkin’s lymphoma in childhood and adolescence. Clin Transl Imaging. 2015;3:309–19.

    Article  Google Scholar 

  3. Cottereau AS, Versari A, Loft A, et al. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial. Blood. 2018;131:1456–63.

    Article  CAS  PubMed  Google Scholar 

  4. Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma. BMC Cancer. 2018;18(1):521. https://doi.org/10.1186/s12885-018-4432-4.PMID:29724189;PMCID:PMC5934894.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kobe C, Goergen H, Baues C, et al. Outcome-based interpretation of early interim PET in advanced stage Hodgkin lymphoma. Blood. 2018;132(21):2273–9.

    Article  CAS  PubMed  Google Scholar 

  6. Barrington SF, Meignan M. Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden. J Nucl Med. 2019;60(8):1096–102. https://doi.org/10.2967/jnumed.119.227249.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Post-Graduate School of Nuclear Medicine, Università degli studi di Milano Bicocca, Milano, Italy

    Sara Pacella

Authors
  1. Sara Pacella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara Pacella.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.

Conflict of interest

The author declares no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Hematology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pacella, S. Prognostic role of metabolic parameters (MTV and TLG) of staging PET/CT in the pediatric population with Hodgkin’s lymphoma: an open discussion. Eur J Nucl Med Mol Imaging 50, 12–13 (2022). https://doi.org/10.1007/s00259-022-05990-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-022-05990-8

Search

Navigation